Literature DB >> 163857

Complement biosynthesis in vitro by rat hepatoma cell strains.

R C Strunk, A H Tashjian, H R Colten.   

Abstract

Four separate rat hepatoma strains were examined for their capacity to synthesize complement (C). None of the strains synthesized detectable amounts of the first components (C-1), and only one strain (7800C-1) produced the fourth component (C4). However, each of the strains synthesized significant amounts of biologically active C-2 and C-3. Three of the four strains also produced C-5 and the natural inhibitor of C-1 (C1 INH). Two control rat cell strains (fibroblast and pituitary) did not synthesize any detectable C components. Production of C, studied extensively in 7800C-1 and H-4, was reversibly inhibited by cycloheximide (2 mug/ml) and [ 14-C ] amino acids were incorporated into C-2, C-3, and C-1 INH. As assessed by gel filtration, the elution positions of the C components synthesized by the cells in culture were similar to those of the corresponding proteins in normal rat serum. Hydrocortisone (10-6 to 10-7 M) stimulated the production of C-3 by H-4 but C-2 and C-5 production were not affected. These C-producing hepatoma cells may prove useful for studies of the control of C biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163857

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

2.  Analysis of synthetic sites of fourth and fifth components of serum complement system in allogeneic bone marrow chimaeras.

Authors:  L Geng; K Iwabuchi; S Sakai; M Ogasawara; M Fujita; K Ogasawara; M Kakinuma; R A Good; K Morikawa; K Onoé
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

3.  Quantitative determination of complement components produced by purified hepatocytes.

Authors:  G Ramadori; H Rasokat; R Burger; K H Meyer Zum Büschenfelde; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

4.  Biosynthesis of the third component of complement in rat liver epithelial cell lines and its stimulation by effector molecules from cultured human mononuclear cells.

Authors:  M Guiguet; M F Exilie Frigere; M C Dethieux; Y Bidan; G Mack
Journal:  In Vitro Cell Dev Biol       Date:  1987-12

5.  Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide.

Authors:  R C Strunk; A S Whitehead; F S Cole
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

6.  Isolation and analysis of genomic DNA clones encoding the third component of mouse complement.

Authors:  K Wiebauer; H Domdey; H Diggelmann; G Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Long-term biosynthesis of complement component C3 and alpha-1 acid glycoprotein by adult rat hepatocytes in a co-culture system with an epithelial liver cell-type.

Authors:  J P Lebreton; M Daveau; M Hiron; M Fontaine; D Biou; D Gilbert; C Guguen-Guillouzo
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

8.  Complement biosynthesis by the human hepatoma-derived cell line HepG2.

Authors:  K M Morris; D P Aden; B B Knowles; H R Colten
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

9.  Biosynthesis of complement components by cultured rat hepatocytes.

Authors:  R Anthony; L Morrison; R N MacSween; K Whaley
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

10.  Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans.

Authors:  L P Einstein; P J Hansen; M Ballow; A E Davis; J S Davis; C A Alper; F S Rosen; H R Colten
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.